Skip to content
1887

Abstract

Innovative antifungal therapies are of crucial importance to combat the potentially life-threatening infections linked to the multidrug-resistant fungal pathogen . Induction of regulated cell death, apoptosis, could provide an outline for future therapeutics. Human antimicrobial peptides (AMPs), well-known antifungal compounds, have shown the ability to induce apoptosis in pathogenic fungi.

Although it is known that AMPs possess antifungal activity against , their ability to induce apoptosis requires further investigations.

This study evaluated the effects of AMPs on the induction of apoptosis in .

Human neutrophil peptide-1 (HNP-1), human β-Defensins-3 (hBD-3) and human salivary histatin 5 (His 5) were assessed against two clinical isolates. Apoptosis hallmarks were examined using FITC-Annexin V/PI double labelling assay and terminal deoxynucleotidyl transferase deoxynucleotidyl transferase nick-end labelling (TUNEL) to detect phosphatidylserine externalization and DNA fragmentation, respectively. Then, several intracellular triggers were studied using JC-10 staining, spectrophotometric assay and 2′,7′-dichlorofluorescin diacetate staining to measure the mitochondrial membrane potential, cytochrome-c release and reactive oxygen species (ROS) production, respectively.

FITC-Annexin V/PI staining and TUNEL analysis revealed that exposure of cells to HNP-1 and hBD-3 triggered both early and late apoptosis, while His 5 caused significant necrosis. Furthermore, HNP-1 and hBD-3 induced significant mitochondrial membrane depolarization, which resulted in substantial cytochrome c release. In contrast to His 5, which showed minimal mitochondrial depolarization and no cytochrome c release. At last, all peptides significantly increased ROS production, which is related to both types of cell death. Therefore, these peptides represent promising and effective antifungal agents for treating invasive infections caused by multidrug-resistant

Funding
This study was supported by the:
  • National Health Laboratory Service (Award RA21-013)
    • Principle Award Recipient: MrudulaPatel
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001835
2024-05-14
2025-04-20
Loading full text...

Full text loading...

References

  1. Ahmad S, Alfouzan W. Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms 2021; 9:807 [View Article] [PubMed]
    [Google Scholar]
  2. Chen J, Tian S, Han X, Chu Y, Wang Q et al. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis 2020; 20:827 [View Article] [PubMed]
    [Google Scholar]
  3. Biagi MJ, Wiederhold NP, Gibas C, Wickes BL, Lozano V et al. Development of high-level echinocandin resistance in a patient with recurrent Candida auris Candidemia secondary to chronic Candiduria. Open Forum Infect Dis 2019; 6:ofz262 [View Article] [PubMed]
    [Google Scholar]
  4. Lamoth F, Lewis RE, Kontoyiannis DP. Investigational antifungal agents for invasive mycoses: a clinical perspective. Clin Infect Dis 2022; 75:534–544 [View Article] [PubMed]
    [Google Scholar]
  5. Swidergall M, Ernst JF. Interplay between Candida albicans and the antimicrobial peptide armory. Eukaryot Cell 2014; 13:950–957 [View Article] [PubMed]
    [Google Scholar]
  6. Bowdish DME, Davidson DJ, Hancock REW. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci 2005; 6:35–51 [View Article] [PubMed]
    [Google Scholar]
  7. Boto A, Pérez de la Lastra JM, González CC. The road from host-defense peptides to a new generation of antimicrobial drugs. Molecules 2018; 23:311 [View Article] [PubMed]
    [Google Scholar]
  8. Kumar P, Kizhakkedathu JN, Straus SK. Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules 2018; 8:4 [View Article] [PubMed]
    [Google Scholar]
  9. Teixeira V, Feio MJ, Bastos M. Role of lipids in the interaction of antimicrobial peptides with membranes. Prog Lipid Res 2012; 51:149–177 [View Article] [PubMed]
    [Google Scholar]
  10. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 2005; 3:238–250 [View Article] [PubMed]
    [Google Scholar]
  11. Yeaman MR, Büttner S, Thevissen K. Regulated cell death as a therapeutic target for novel antifungal peptides and biologics. Oxid Med Cell Longev 2018; 2018:5473817 [View Article] [PubMed]
    [Google Scholar]
  12. Rockenfeller P, Madeo F. Apoptotic death of ageing yeast. Exp Gerontol 2008; 43:876–881 [View Article] [PubMed]
    [Google Scholar]
  13. Strich R. Programmed cell death initiation and execution in budding yeast. Genetics 2015; 200:1003–1014 [View Article] [PubMed]
    [Google Scholar]
  14. Herker E, Jungwirth H, Lehmann KA, Maldener C, Fröhlich K-U et al. Chronological aging leads to apoptosis in yeast. J Cell Biol 2004; 164:501–507 [View Article] [PubMed]
    [Google Scholar]
  15. Ludovico P, Sousa MJ, Silva MT, Leão CL, Côrte-Real M. Saccharomyces cerevisiae commits to a programmed cell death process in response to acetic acid. Microbiology 2001; 147:2409–2415 [View Article] [PubMed]
    [Google Scholar]
  16. Huh G-H, Damsz B, Matsumoto TK, Reddy MP, Rus AM et al. Salt causes ion disequilibrium-induced programmed cell death in yeast and plants. Plant J 2002; 29:649–659 [View Article] [PubMed]
    [Google Scholar]
  17. Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals 2014; 7:545–594 [View Article] [PubMed]
    [Google Scholar]
  18. Fazly Bazzaz BS, Seyedi S, Hoseini Goki N, Khameneh B. Human antimicrobial peptides: spectrum, mode of action and resistance mechanisms. Int J Pept Res Ther 2021; 27:801–816 [View Article]
    [Google Scholar]
  19. Shaban S, Patel M, Ahmad A. Fungicidal activity of human antimicrobial peptides and their synergistic interaction with common antifungals against multidrug-resistant Candida auris. Int Microbiol 2023; 26:165–177 [View Article] [PubMed]
    [Google Scholar]
  20. CLSI Reference method for broth dilution antifungal susceptibility testing of yeasts. In CLSI Standard M27, 4th edn. Wayne, PA: Clinical and Laboratory Standards Institute; 2017
    [Google Scholar]
  21. Khan A, Ahmad A, Khan LA, Manzoor N. Ocimum sanctum (L.) essential oil and its lead molecules induce apoptosis in Candida albicans. Res Microbiol 2014; 165:411–419 [View Article] [PubMed]
    [Google Scholar]
  22. Wu X-Z, Chang W-Q, Cheng A-X, Sun L-M, Lou H-X. Plagiochin E, an antifungal active macrocyclic bis(bibenzyl), induced apoptosis in Candida albicans through a metacaspase-dependent apoptotic pathway. Biochimica et Biophysica Acta (BBA) - General Subjects 2010; 1800:439–447 [View Article]
    [Google Scholar]
  23. Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N et al. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 2002; 46:3113–3117 [View Article] [PubMed]
    [Google Scholar]
  24. Kari S, Subramanian K, Altomonte IA, Murugesan A, Yli-Harja O et al. Programmed cell death detection methods: a systematic review and a categorical comparison. Apoptosis 2022; 27:482–508 [View Article] [PubMed]
    [Google Scholar]
  25. Kyrylkova K, Kyryachenko S, Leid M, Kioussi C. Detection of apoptosis by TUNEL assay. Methods Mol Biol 2012; 887:41–47 [View Article] [PubMed]
    [Google Scholar]
  26. Younes N, Alsahan BS, Al-Mesaifri AJ, Da’as SI, Pintus G et al. JC-10 probe as a novel method for analyzing the mitochondrial membrane potential and cell stress in whole zebrafish embryos. Toxicol Res 2022; 11:77–87 [View Article] [PubMed]
    [Google Scholar]
  27. Jacobs SE, Jacobs JL, Dennis EK, Taimur S, Rana M et al. Candida auris pan-drug-resistant to four classes of antifungal agents. Antimicrob Agents Chemother 2022; 66:e0005322 [View Article] [PubMed]
    [Google Scholar]
  28. Buda De Cesare G, Cristy SA, Garsin DA, Lorenz MC. Antimicrobial peptides: a new frontier in antifungal therapy. mBio 2020; 11:e02123-20 [View Article] [PubMed]
    [Google Scholar]
  29. Struyfs C, Cammue BPA, Thevissen K. Membrane-interacting antifungal peptides. Front Cell Dev Biol 2021; 9:649875 [View Article] [PubMed]
    [Google Scholar]
  30. Grosfeld EV, Bidiuk VA, Mitkevich OV, Ghazy ESMO, Kushnirov VV et al. A systematic survey of characteristic features of yeast cell death triggered by external factors. J Fungi 2021; 7:886 [View Article] [PubMed]
    [Google Scholar]
  31. Phillips AJ, Sudbery I, Ramsdale M. Apoptosis induced by environmental stresses and amphotericin B in Candida albicans. Proc Natl Acad Sci U S A 2003; 100:14327–14332 [View Article] [PubMed]
    [Google Scholar]
  32. Hao B, Cheng S, Clancy CJ, Nguyen MH. Caspofungin kills Candida albicans by causing both cellular apoptosis and necrosis. Antimicrob Agents Chemother 2013; 57:326–332 [View Article] [PubMed]
    [Google Scholar]
  33. Perrone GG, Tan SX, Dawes IW. Reactive oxygen species and yeast apoptosis. Biochim Biophys Acta 2008; 1783:1354–1368 [View Article] [PubMed]
    [Google Scholar]
  34. Poon IKH, Hulett MD, Parish CR. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ 2010; 17:381–397 [View Article] [PubMed]
    [Google Scholar]
  35. Zhang Y, Chen X, Gueydan C, Han J. Plasma membrane changes during programmed cell deaths. Cell Res 2018; 28:9–21 [View Article] [PubMed]
    [Google Scholar]
  36. Chaurio RA, Janko C, Muñoz LE, Frey B, Herrmann M et al. Phospholipids: key players in apoptosis and immune regulation. Molecules 2009; 14:4892–4914 [View Article] [PubMed]
    [Google Scholar]
  37. Carmona-Gutierrez D, Eisenberg T, Büttner S, Meisinger C, Kroemer G et al. Apoptosis in yeast: triggers, pathways, subroutines. Cell Death Differ 2010; 17:763–773 [View Article] [PubMed]
    [Google Scholar]
  38. Vylkova S, Nayyar N, Li W, Edgerton M. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob Agents Chemother 2007; 51:154–161 [View Article] [PubMed]
    [Google Scholar]
  39. Chen RC, Lan CY. Human antimicrobial peptide hepcidin 25-induced apoptosis in Candida albicans. Microorganisms 2020; 8:585 [View Article] [PubMed]
    [Google Scholar]
  40. Andrés MT, Viejo-Díaz M, Fierro JF. Human lactoferrin induces apoptosis-like cell death in Candida albicans: critical role of K+-channel-mediated K+ efflux. Antimicrob Agents Chemother 2008; 52:4081–4088 [View Article] [PubMed]
    [Google Scholar]
  41. Lee J, Hwang J-S, Hwang I-S, Cho J, Lee E et al. Coprisin-induced antifungal effects in Candida albicans correlate with apoptotic mechanisms. Free Radic Biol Med 2012; 52:2302–2311 [View Article] [PubMed]
    [Google Scholar]
  42. Aerts AM, François IEJA, Meert EMK, Li Q-T, Cammue BPA et al. The antifungal activity of RsAFP2, a plant defensin from raphanus sativus, involves the induction of reactive oxygen species in Candida albicans. J Mol Microbiol Biotechnol 2007; 13:243–247 [View Article] [PubMed]
    [Google Scholar]
  43. Pereira C, Silva RD, Saraiva L, Johansson B, Sousa MJ et al. Mitochondria-dependent apoptosis in yeast. Biochim Biophys Acta 2008; 1783:1286–1302 [View Article] [PubMed]
    [Google Scholar]
  44. Ludovico P, Rodrigues F, Almeida A, Silva MT, Barrientos A et al. Cytochrome c release and mitochondria involvement in programmed cell death induced by acetic acid in Saccharomyces cerevisiae. Mol Biol Cell 2002; 13:2598–2606 [View Article] [PubMed]
    [Google Scholar]
  45. Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB et al. Mitochondrial membrane potential. Anal Biochem 2018; 552:50–59 [View Article] [PubMed]
    [Google Scholar]
  46. Guaragnella N, Zdralević M, Antonacci L, Passarella S, Marra E et al. The role of mitochondria in yeast programmed cell death. Front Oncol 2012; 2:70 [View Article] [PubMed]
    [Google Scholar]
  47. Pathirana RU, Friedman J, Norris HL, Salvatori O, McCall AD et al. Fluconazole-resistant Candida auris is susceptible to salivary histatin 5 killing and to intrinsic host defenses. Antimicrob Agents Chemother 2018; 62:e01872-17 [View Article] [PubMed]
    [Google Scholar]
  48. Edgerton M, Koshlukova SE, Lo TE, Chrzan BG, Straubinger RM et al. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J Biol Chem 1998; 273:20438–20447 [View Article] [PubMed]
    [Google Scholar]
  49. Petruzzelli R, Clementi ME, Marini S, Coletta M, Di Stasio E et al. Respiratory inhibition of isolated mammalian mitochondria by salivary antifungal peptide histatin-5. Biochem Biophys Res Commun 2003; 311:1034–1040 [View Article] [PubMed]
    [Google Scholar]
  50. Komatsu T, Salih E, Helmerhorst EJ, Offner GD, Oppenheim FG. Influence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry. J Proteome Res 2011; 10:646–655 [View Article] [PubMed]
    [Google Scholar]
  51. Farrugia G, Balzan R. Oxidative stress and programmed cell death in yeast. Front Oncol 2012; 2:64 [View Article] [PubMed]
    [Google Scholar]
  52. Costa V, Moradas-Ferreira P. Oxidative stress and signal transduction in Saccharomyces cerevisiae: insights into ageing, apoptosis and diseases. Mol Aspects Med 2001; 22:217–246 [View Article] [PubMed]
    [Google Scholar]
  53. Cho J, Lee DG. Oxidative stress by antimicrobial peptide pleurocidin triggers apoptosis in Candida albicans. Biochimie 2011; 93:1873–1879 [View Article] [PubMed]
    [Google Scholar]
  54. Veerman ECI, Nazmi K, Van’t Hof W, Bolscher JGM, Den Hertog AL et al. Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5. Biochem J 2004; 381:447–452 [View Article] [PubMed]
    [Google Scholar]
  55. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 2007; 12:913–922 [View Article] [PubMed]
    [Google Scholar]
  56. Villalpando-Rodriguez GE, Gibson SB. Reactive oxygen species (ROS) regulates different types of cell death by acting as a rheostat. Oxid Med Cell Longev 2021; 2021:9912436 [View Article] [PubMed]
    [Google Scholar]
  57. Papo N, Shai Y. Effect of drastic sequence alteration and D-amino acid incorporation on the membrane binding behavior of lytic peptides. Biochemistry 2004; 43:6393–6403 [View Article] [PubMed]
    [Google Scholar]
  58. Svenson J, Stensen W, Brandsdal B-O, Haug BE, Monrad J et al. Antimicrobial peptides with stability toward tryptic degradation. Biochemistry 2008; 47:3777–3788 [View Article] [PubMed]
    [Google Scholar]
  59. Ikonomova SP, Moghaddam-Taaheri P, Wang Y, Doolin MT, Stroka KM et al. Effects of histatin 5 modifications on antifungal activity and kinetics of proteolysis. Protein Sci 2020; 29:480–493 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001835
Loading
/content/journal/jmm/10.1099/jmm.0.001835
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error